Dynamic behavior of metabolic syndrome progression: a comprehensive systematic review on recent discoveries

BMC Endocrine Disorders

Table 4 The largest and smallest probability values by each state

	No component		Overweight or obesity		hypertension		dyslipidemia		hyperglycemia		2-component		≥3 component (MetS)
	Max (%)	Min (%)	Max (%)	Min (%)	Max (%)	Min (%)	Max (%)	Min (%)	Max (%)	Min (%)	Max (%)	Min (%)	Max (%)	Min (%)
No component			10.15^a	.91^a	12.11^a	.41^b	13.33^b	.81^b	11.24^a	.16^b	8.33^b	.42^b	3.09^a	.41^b
overweight or obesity	37.81^b	2.16^a			3.23^b	0^c	5.38^b	0^c	2.46^b	0^c	28.75^a	3.41^b	11.76^b	1.25^b
hypertension	24.26^b	0‡	8.48^a	0^c			3.96^b	0^c	2.42^a	0^c	32.76^b	3.38^a	13.79^b	.79^a
dyslipidemia	55.11^b	7.91^b	7.14^b	0^c	9.52^b	0^c			4.76^b	0^c	29.73^a	1.43^b	8.63^a	0^c
hyperglycemia	23.28	0^c	5.19^b	0^c	6.9^a	0^c	6.9^a	0^c			43.75^a	3.1^b	30.77^b	0^c
2-component	24.68^b	0^c	21.56^a	0^c	26.15^a	0^c	12.99^a	0^c	25.91^b	0^c			31.49^a	4.21^b
≥3 component (MS)	14.29^b	0^c	10^a	0^c	13.52^b	.45^b	4.76^b	0^c	3.9^b	0^c	42.31^b	2.71^b

ISSN: 1472-6823